Efficacy of once-weekly semaglutide vs empagliflozin added to metformin in type 2 diabetes: patient-level meta-analysis

The Journal of Clinical Endocrinology & Metabolism

https://doi.org/10.1210/clinem/dgaa577

Published: 22 August 2020

Inicie sesión para enviar comentarios

Artículos Relacionadas

Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment

Radiofrequency ablation and thyroid nodules: updated systematic review

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Bariatric Surgery: Remission of Inflammation, Cardiometabolic Benefits, and Common Adverse Effects

Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling

Early diagnosis and improved management of patients with diabetes through strategic and automated test algorithms via primary care

The role of surgical adrenalectomy in primary aldosteronism

A Pituitary Society update to acromegaly management guidelines

Management of hypertriglyceridemia

Methimazole Treatment and Risk of Acute Pancreatitis: A Population-based Cohort Study

Agenda

Enero 2021

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
28	29	30	31	1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Top